Filtered By:
Drug: Temodar
Countries: Turkey Health
This page shows you your search results in order of date.
Order by Relevance | Date
Total 111 results found since Jan 2013.
Efficacy of Capecitabine and Temozolomide Regimen in Neuroendocrine Tumors: Data From the Turkish Oncology Group
CONCLUSIONS AND RELEVANCE: The substantial superior outcomes in patients receiving first-line CAPTEM treatment highlight its potential as an effective treatment strategy for patients with metastatic NET.PMID:37676712 | DOI:10.1093/oncolo/oyad257
Source: The Oncologist - September 7, 2023 Category: Cancer & Oncology Authors: Çağlar Ünal Abdulmunir Azizy Senem Karabulut Didem Ta ştekin Arif Aky ıldız Serkan Ya şar Şuayib Yalçın Ey üp Çoban T ürkkan Evrensel Ziya Kalkan Zeynep Oru ç S ümeyra Derin Zeynep Hande Turna Do ğan Bayram Fahriye Tu ğba Köş Mehmet Ali Source Type: research
The Assessment of Clinical Outcomes and Prognostic Factors in Glioblastoma Patients
CONCLUSION: According to the literature in our study, a multidisciplinary and intensive treatment approach using modern techniques improved the OS of glioblastoma patients. Furthermore, larger RT fields were not associated with better outcomes in glioblastoma patients. As a result, lymphocyte-sparing RT may be more beneficial in increasing patients\' compliance to adjuvant TMZ, which is an important prognostic factor of OS.PMID:37528719 | DOI:10.5137/1019-5149.JTN.40460-22.3
Source: Turkish Neurosurgery - August 2, 2023 Category: Neurosurgery Authors: Niyazi Volkan Demircan Ozge Petek Erpolat Caglar Guzel Ertugrul Senturk Huseyin Bora Eray Karahacioglu Source Type: research
